<i>TP53</i>mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
Jeremy Chien(University of California, Davis), Ellen L. Goode(Mayo Clinic in Arizona)
Cited by 51
Related Papers
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
|JNCI Journal of the National Cancer Institute|2015|441
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
|Clinical Cancer Research|2014|160
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
|Circulation|2022|106